Boehringer Ingelheim Animal Health USA Inc. has recalled 13,242 bottles of Semintra (telmisartan oral solution) 10 mg/mL, a medication used for cats. This recall was initiated because the product was found to be outside of its required pH specifications and showed the formation of particles (precipitation). If you have this medication, you should consult your veterinarian regarding your cat's health and stop using the affected batches immediately.
The medication's chemical balance (pH) is incorrect and solid particles have formed in the solution, which may compromise the drug's effectiveness or safety when administered to cats.
You have 2 options:
Recall #: V-0149-2023; Marketed by Boehringer Ingelheim Animal Health USA Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response